Lifestyle Intervention With Smartphone App and isCGM for People at High Risk of Type 2 Diabetes: Randomized Trial

被引:3
|
作者
Kitazawa, Masaru [1 ]
Takeda, Yasunaga [1 ]
Hatta, Mariko [1 ]
Horikawa, Chika [2 ]
Sato, Takaaki [1 ]
Osawa, Taeko [1 ]
Ishizawa, Masahiro [1 ]
Suzuki, Hiroshi [1 ]
Matsubayashi, Yasuhiro [1 ]
Fujihara, Kazuya [1 ]
Yamada, Takaho [1 ]
Sone, Hirohito [1 ,3 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata 9518510, Japan
[2] Univ Niigata Prefecture, Fac Human Life Studies, Dept Hlth & Nutr, Niigata 9500806, Japan
[3] Niigata Univ, Dept Internal Med, Fac Med, 1-754 Asahimachi, Niigata 9518510, Japan
来源
关键词
continuous blood glucose monitor; prevention; prospective randomized trial; smartphone; educational intervention; DOSE-RESPONSE METAANALYSIS; HEALTH MANAGEMENT CENTER; PHYSICAL-ACTIVITY; GLUCOSE-LEVELS; JAPANESE; INDIVIDUALS; PREVENTION; HBA1C;
D O I
10.1210/clinem/dgad639
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: Although conventional interventions for people at high risk of developing type 2 diabetes are usually conducted face-to-face, such interventions are burdensome for health care providers. We developed a lifestyle intervention program combining lifestyle coaching via a smartphone application augmented by intermittently scanned continuous glucose monitoring without burdening health care providers. Its effectiveness for glycemic control and body weight reduction in people at risk of type 2 diabetes was investigated.Materials and Methods: For this 12-week randomized unblinded trial with offline recruitment, participants with a hemoglobin A1c level of 5.6% to 6.4% or a fasting blood glucose of 110 to 125 mg/dL and body mass index (BMI) >23 kg/m2 but <40 kg/m(2) were randomly assigned to the intervention group (App) and control group (C). The primary endpoint was the difference in time in range of blood glucose between 70 and 140 mg/dL (3.9-7.8 mmol/L) before and after the study period between the 2 groups.Results: Among 168 patients (mean age, 48.1 years; mean BMI, 26.6 kg/m(2); and male, 80.4%), 82 and 86 were assigned to the App group and C group, respectively. After 12 weeks, time in range of blood glucose at 70 to 140 mg/dL significantly improved in the App group compared with the C group (-2.6 minutes/day vs +31.5 minutes/day, P = .03). Changes in time above range did not differ, whereas time below range (blood glucose <70 mg/dL; +23.5 minutes/day vs -8.9 minutes/day, P = .02) improved in the App group. BMI (-0.26 vs -0.59, P = .017) was reduced in the App group compared with the C group.Conclusion: Intervention with a smartphone app and intermittently scanned continuous glucose monitoring increased glycemic control accompanied by decreased carbohydrate intake and weight loss. Further trials are needed to confirm whether these interventions can reduce incident type 2 diabetes.
引用
收藏
页码:1060 / 1070
页数:11
相关论文
共 50 条
  • [1] Lifestyle Intervention Program with Smartphone App Augmented by Intermittently Scanned Continuous Glucose Monitoring for People at High Risk of Diabetes-Randomized Controlled Trial
    Kitazawa, Masaru
    Suzuki, Hiroshi
    Horikawa, Chika
    Takeda, Yasunaga
    Ikeda, Izumi
    Hatta, Mariko
    Iwanaga, Midori
    Yamada, Takaho
    Fujihara, Kazuya
    Sone, Hirohito
    DIABETES, 2023, 72
  • [2] Effects of the Lifestyle Intervention Program GLICEMIA in People at Risk for Type 2 Diabetes: A Cluster-Randomized Controlled Trial
    Schmiedel, Karin
    Mayr, Andreas
    Fiessler, Cornelia
    Schlager, Helmut
    Friedland, Kristina
    DIABETES CARE, 2015, 38 (05) : 937 - 939
  • [3] The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial
    Thorsen, Ida Kaer
    Yang, Yanxiang
    Valentiner, Laura Staun
    Gluemer, Charlotte
    Karstoft, Kristian
    Brond, Jan Christian
    Nielsen, Rasmus Oestergaard
    Brons, Charlotte
    Christensen, Robin
    Nielsen, Jens Steen
    Vaag, Allan Arthur
    Pedersen, Bente Klarlund
    Langberg, Henning
    Ried-Larsen, Mathias
    JMIR MHEALTH AND UHEALTH, 2022, 10 (09):
  • [4] A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes
    Kim, Gyuri
    Kim, Seohyun
    Lee, You-Bin
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    BMC MEDICINE, 2024, 22 (01):
  • [5] Results of a 2-year lifestyle intervention for type 2 diabetes: the Reach Ahead for Lifestyle and Health -Diabetes randomized controlled trial
    Wexler, Deborah J.
    Chang, Yuchiao
    Levy, Douglas E.
    Porneala, Bianca
    McCarthy, Jeanna
    Romero, Anthony Rodriguez
    Goldman, Valerie
    Copeland, Paul M.
    Steppel-Reznik, Jeanne
    Delahanty, Linda M.
    OBESITY, 2022, 30 (10) : 1938 - 1950
  • [6] BEHAVIORAL LIFESTYLE INTERVENTION DECREASES RISK IN TYPE 2 DIABETES: RESULTS OF THE CALM-D RANDOMIZED CONTROLLED TRIAL
    Moncrieft, Ashley E.
    Llabre, Maria M.
    McCalla, Judith R.
    Gutt, Miriam
    Mendez, Armando J.
    Gellman, Marc D.
    Goldberg, Ronald B.
    Schneiderman, Neil
    ANNALS OF BEHAVIORAL MEDICINE, 2014, 47 : S182 - S182
  • [7] Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial
    Alonso, Alvaro
    Bahnson, Judy L.
    Gaussoin, Sarah A.
    Bertoni, Alain G.
    Johnson, Karen C.
    Lewis, Cora E.
    Vetter, Marion
    Mantzoros, Christos S.
    Jeffery, Robert W.
    Soliman, Elsayed Z.
    AMERICAN HEART JOURNAL, 2015, 170 (04) : 770 - +
  • [8] Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes
    Corpeleijn, Eva
    Feskens, Edith J. M.
    Jansen, Eugene H. J. M.
    Mensink, Marco
    Saris, Wim H. M.
    Blaak, Ellen E.
    DIABETES CARE, 2007, 30 (12) : 3125 - 3127
  • [9] A Smartphone-App-Based Lifestyle Intervention Program for Weight Loss: Interim Analysis of a Randomized Controlled Trial
    Vaz, Cherie
    Suthar, Akashkumar
    Williams, Kevin Jon
    Parkash, Shanti
    Zhao, Huaqing
    DIABETES, 2017, 66 : LB86 - LB86
  • [10] Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial
    Smith, GD
    Bracha, Y
    Svendsen, KH
    Neaton, JD
    Haffner, SM
    Kuller, LH
    ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 313 - 322